×
NASDAQ : SRTS. Investor Relations. Company Overview. Sensus Healthcare, Inc. (NASDAQ: SRTS) is a medical device company that is committed to enabling non ...
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Find annual and quearterly earnings data for Sensus Healthcare, Inc. Common Stock (SRTS) including earnings per share, earnings forecasts at Nasdaq.com.
(Nasdaq:SRTS), the leading manufacturer of advanced medical devices for non-surgical skin cancer and keloid scar treatment, is proud to announce Sensus […] ...
SRTS:$3.77▽ $-0.04(-1.05%). Overview; Corporate ... Investor Relations. Presentations · Press Releases ... Sensus Healthcare Launches "Fair Deal Agreement" for its ...
People also ask
Sartorius AG Investor Relations. A Trusted Partner for the Biopharmaceutical Industry and Laboratories · Focus on the High-Growth Biopharma Market · Sustainable ...
Welcome to Sensus. Superficial Radiotherapy (SRT) provides a non-surgical alternative for non-melanoma skin cancer and an effective solution for keloids.
Sensus Healthcare Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View SRTS.US financial statements in full.
Missing: relations | Show results with:relations
Find the latest Sensus Healthcare, Inc. (SRTS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Check out our SRTS stock analysis, current SRTS quote, charts, and historical prices for Sensus Healthcare Inc stock.